April 06, 2026
A Delaware federal judge knocked nearly $10 million off a $19.35 million damages award for Natera Inc. on Monday, but added supplemental damages and interest to a patent infringement verdict against Invitae Corp. related to cancer testing technology.
December 01, 2023
A Delaware federal judge has barred Invitae Corp. from using its Personalized Cancer Monitoring test in certain ways that infringe patents owned by Natera Inc., according to a rare injunction made public Friday.
October 18, 2023
ArcherDX wants a Delaware federal judge to throw out a jury finding that it owes $19.35 million in a patent infringement suit from Natera Inc. over patents covering cancer testing products, pointing to a recent case involving Google and Sonos.
September 05, 2023
A Delaware federal judge on Tuesday upheld a pair of Natera Inc. patents covering cancer testing products, rejecting competitor ArcherDX's argument that Natera waited too long before filing for patents and suing ArcherDX for infringement.
June 22, 2023
Genetic testing company Natera Inc. waited until competitor ArcherDX sunk millions into similar cancer testing products before filing for patents and suing ArcherDX for infringement, an "unreasonable" and "unexplained" delay that should bar them from enforcing two patents, ArcherDX argued in Delaware federal court Thursday.
June 15, 2023
A small Virginia cybersecurity company will once again be making the case that Cisco is selling routers that infringe its software patents after a stock conflict sank the startup's $2.75 billion win. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
May 15, 2023
A Delaware federal jury on Monday found that a unit of genetic testing company Invitae owes about $19.35 million for directly infringing three Natera patents covering cancer testing technology.